Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) StudyJanis M. Taube, Cliff C. Hoyt|Journal for ImmunoTherapy of Cancer|2021Cited by 109
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Sufeng Mao et al.|Clinical Cancer Research|2019Cited by 87
Supplementary Data from Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Chandandeep Nagi et al.|Unknown|2023Cited by 0
Data from Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Chandandeep Nagi et al.|Unknown|2023Cited by 0
Data from Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without ChemotherapyCarmine De Angelis, Rachel Schiff, Chandandeep Nagi et al.|Unknown|2023Cited by 0